Vijay Kumar
Stock Analyst at Evercore ISI Group
(2.24)
# 2,681
Out of 4,944 analysts
233
Total ratings
42.54%
Success rate
-4.52%
Average return
Main Sectors:
Stocks Rated by Vijay Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAI Caris Life Sciences | Maintains: Outperform | $33 → $40 | $32.46 | +23.23% | 2 | Aug 13, 2025 | |
| EXAS Exact Sciences | Maintains: Outperform | $68 → $64 | $41.74 | +53.33% | 6 | Aug 8, 2025 | |
| AZTA Azenta | Maintains: In-Line | $35 → $33 | $29.21 | +12.98% | 8 | Aug 5, 2025 | |
| MTD Mettler-Toledo International | Maintains: Outperform | $1,280 → $1,275 | $1,292.89 | -1.38% | 11 | Aug 4, 2025 | |
| AVTR Avantor | Maintains: Outperform | $18 → $16 | $12.66 | +26.38% | 11 | Aug 4, 2025 | |
| EW Edwards Lifesciences | Maintains: In-Line | $77 → $80 | $76.93 | +3.99% | 13 | Jul 25, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: In-Line | $102 → $96 | $101.82 | -5.72% | 13 | Jul 8, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $500 → $480 | $477.41 | +0.54% | 12 | Jul 8, 2025 | |
| SYK Stryker | Maintains: Outperform | $390 → $415 | $376.61 | +10.19% | 11 | Jul 8, 2025 | |
| RVTY Revvity | Maintains: Outperform | $116 → $115 | $88.00 | +30.68% | 2 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $103 → $106 | $92.08 | +15.12% | 5 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $470 → $550 | $478.19 | +15.02% | 13 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $116 → $128 | $97.38 | +31.44% | 7 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $62 → $68 | $67.95 | +0.07% | 15 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $46 | $28.75 | +60.00% | 4 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $226 | $205.72 | +9.86% | 3 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $16 → $16 | - | - | 9 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $44 → $42 | $23.98 | +75.15% | 7 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $140 → $145 | $131.02 | +10.67% | 11 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $125 → $130 | $117.32 | +10.81% | 4 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $44 → $49 | $45.77 | +7.06% | 6 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $3 | $2.81 | +6.95% | 6 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $96 → $85 | $74.41 | +14.23% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $110 → $112 | $102.64 | +9.12% | 6 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $207 → $202 | $142.83 | +41.43% | 6 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $18 → $30 | $11.34 | +164.55% | 11 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $335 → $355 | $285.52 | +24.33% | 8 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $52 → $56 | $27.45 | +104.01% | 5 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $160 | $63.27 | +152.88% | 7 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $286 → $290 | $194.96 | +48.75% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $1.20 | +483.33% | 1 | May 31, 2022 |
Caris Life Sciences
Aug 13, 2025
Maintains: Outperform
Price Target: $33 → $40
Current: $32.46
Upside: +23.23%
Exact Sciences
Aug 8, 2025
Maintains: Outperform
Price Target: $68 → $64
Current: $41.74
Upside: +53.33%
Azenta
Aug 5, 2025
Maintains: In-Line
Price Target: $35 → $33
Current: $29.21
Upside: +12.98%
Mettler-Toledo International
Aug 4, 2025
Maintains: Outperform
Price Target: $1,280 → $1,275
Current: $1,292.89
Upside: -1.38%
Avantor
Aug 4, 2025
Maintains: Outperform
Price Target: $18 → $16
Current: $12.66
Upside: +26.38%
Edwards Lifesciences
Jul 25, 2025
Maintains: In-Line
Price Target: $77 → $80
Current: $76.93
Upside: +3.99%
Zimmer Biomet Holdings
Jul 8, 2025
Maintains: In-Line
Price Target: $102 → $96
Current: $101.82
Upside: -5.72%
Thermo Fisher Scientific
Jul 8, 2025
Maintains: Outperform
Price Target: $500 → $480
Current: $477.41
Upside: +0.54%
Stryker
Jul 8, 2025
Maintains: Outperform
Price Target: $390 → $415
Current: $376.61
Upside: +10.19%
Revvity
Jul 8, 2025
Maintains: Outperform
Price Target: $116 → $115
Current: $88.00
Upside: +30.68%
Jul 8, 2025
Maintains: Outperform
Price Target: $103 → $106
Current: $92.08
Upside: +15.12%
Jul 8, 2025
Maintains: In-Line
Price Target: $470 → $550
Current: $478.19
Upside: +15.02%
Jul 8, 2025
Maintains: Outperform
Price Target: $116 → $128
Current: $97.38
Upside: +31.44%
Jul 8, 2025
Maintains: In-Line
Price Target: $62 → $68
Current: $67.95
Upside: +0.07%
Jul 8, 2025
Maintains: Outperform
Price Target: $48 → $46
Current: $28.75
Upside: +60.00%
Jul 8, 2025
Maintains: Outperform
Price Target: $230 → $226
Current: $205.72
Upside: +9.86%
Jul 8, 2025
Maintains: Outperform
Price Target: $16 → $16
Current: -
Upside: -
Jul 8, 2025
Maintains: Outperform
Price Target: $44 → $42
Current: $23.98
Upside: +75.15%
Jul 8, 2025
Maintains: Outperform
Price Target: $140 → $145
Current: $131.02
Upside: +10.67%
Jul 8, 2025
Maintains: In-Line
Price Target: $125 → $130
Current: $117.32
Upside: +10.81%
Jun 4, 2025
Maintains: In-Line
Price Target: $44 → $49
Current: $45.77
Upside: +7.06%
May 19, 2025
Maintains: In-Line
Price Target: $3
Current: $2.81
Upside: +6.95%
May 1, 2025
Maintains: Outperform
Price Target: $96 → $85
Current: $74.41
Upside: +14.23%
Apr 24, 2025
Maintains: Outperform
Price Target: $110 → $112
Current: $102.64
Upside: +9.12%
Jan 17, 2025
Maintains: Outperform
Price Target: $207 → $202
Current: $142.83
Upside: +41.43%
Dec 2, 2024
Upgrades: Outperform
Price Target: $18 → $30
Current: $11.34
Upside: +164.55%
Oct 1, 2024
Maintains: In-Line
Price Target: $335 → $355
Current: $285.52
Upside: +24.33%
Oct 1, 2024
Maintains: Outperform
Price Target: $52 → $56
Current: $27.45
Upside: +104.01%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $160
Current: $63.27
Upside: +152.88%
Oct 1, 2024
Maintains: Outperform
Price Target: $286 → $290
Current: $194.96
Upside: +48.75%
May 31, 2022
Initiates: Outperform
Price Target: $7
Current: $1.20
Upside: +483.33%